Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level

References

• ShiQSmithTGMichonskiJDSteinKDKawCKCleelandCSSymptom burden in cancer survivors one year after diagnosis: a report form the American Cancer Society’s Studies of Cancer SurvivorsCancer2012117122779279021495026
   PubMed Web of Science ®Google Scholar
• BurkettVSCleelandCSSymptom burden in cancer survivorshipJ Cancer Surviv20071216717518648958
   PubMedGoogle Scholar
• WuHSHardenJKSymptom burden and quality of life in survivorship: a review of the literatureCancer Nurs2015381E29E5424831042
   PubMed Web of Science ®Google Scholar
• SpiegelDGiese-DavisJDepression and cancer: mechanisms and disease progressionBiol Psychiatr2003543269282
   PubMed Web of Science ®Google Scholar
• BarsevickAFrostMZwindermanAHallPHalyardMGENEQOL ConsortiumI’m so tired: biological and genetic mechanisms of cancer-related fatigueQual Life Res201119101419142720953908
   PubMed Web of Science ®Google Scholar
• VardyJWefelJSAhlesTTannockIFSchagenSBCancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshopAnn Oncol200819462362917974553
   PubMed Web of Science ®Google Scholar
• FalletiMGSanfilippoAMaruffPWeihLPhillipsKAThe nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literatureBrain Cogn2005591607015975700
   PubMed Web of Science ®Google Scholar
• BenderCMSereikaSMBrufskyAMMemory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancerMenopause201014699599817898668
   PubMed Web of Science ®Google Scholar
• CastellonSAGanzPABowerJEPetersenLAbrahamLGreendaleGANeurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifenJ Clin Exp Neuropsychol200426795596915742545
   PubMed Web of Science ®Google Scholar
• BreckenridgeLMBrunsGLToddBLFeuersteinMCognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivorsPsychooncology201253435320967847
   PubMed Web of Science ®Google Scholar
• LejbakLVrbancicMCrossleyMEndocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancerJ Clin Exp Neuropsychol201032883684620336566
   PubMed Web of Science ®Google Scholar
• SchilderCMSeynaeveCBeexLVEffects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trialJ Clin Oncol20102881294130020142601
   PubMed Web of Science ®Google Scholar
• ShillingVJenkinsVFallowfieldLHowellTThe effects of hormone therapy on cognition in breast cancerJ Steroid Biochem Mol Biol2003863–540541214623538
   PubMed Web of Science ®Google Scholar
• JenkinsVShillingVFallowfieldLHowellAHuttonSDoes hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition?: a pilot studyPsychooncology2004131616614745746
   PubMed Web of Science ®Google Scholar
• HermelinkKUntchMLuxMPCognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal studyCancer200710991905191317351951
   PubMed Web of Science ®Google Scholar
• WefelJSLenziRTheriaultRBuzdarAUCruickshankSMeyersCA“Chemobrain” in breast carcinoma?: a prologueCancer2004101346647515274059
   PubMed Web of Science ®Google Scholar
• AhlesTAAvenueLYorkNSaykinAJMcdonaldBCKaufmanPACognitive function in breast cancer patients prior to adjuvant treatmentBreast Cancer Res Treat2011110114315217674194
   PubMed Web of Science ®Google Scholar
• BenderCMSereikaSMRyanCMBrufskyAMPuhallaSBergaSLDoes lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?Menopause20132091823266836
   PubMed Web of Science ®Google Scholar
• SchagenSBMullerMJBoogerdWMellenberghGJvan DamFSChange in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patientsJ Natl Cancer Inst200698231742174517148777
   PubMedGoogle Scholar
• ZhangYSchnabelCASchroederBEBreast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrenceClin Cancer Res201319154196420523757354
   PubMed Web of Science ®Google Scholar
• SgroiDCCarneyEZarrellaEPrediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarkerJ Natl Cancer Inst2013105141036104223812955
   PubMedGoogle Scholar
• SgroiDCSestakICuzickJPrediction of late distant recurrence in patients with oestrogen-receptor positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study populationLancet Oncol201314111067107624035531
   PubMed Web of Science ®Google Scholar
• TuttAWangARowlandCRisk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signatureBMC Cancer2008833919025599
   PubMed Web of Science ®Google Scholar
• Genomic Health®, IncOncotype DX^® Breast Cancer Assay Invasive Sales Aid Available from: http://breast-cancer.oncotypedx.com/en-US/Professional-Invasive/~/media/ODX-Breast/Images/Invasive/Invasive-SalesAid_11-2.pdfAccessed November 3, 2016
   Google Scholar
• Genomic Health®, IncOncotype DX^® Breast Cancer Assay DCIS Sales Aid Available from: http://breast-cancer.oncotypedx.com/en-US/Professional-DCIS/~/media/ODX-Breast/Files/Downloads/DCIS_Sales_Aid.pdfAccessed November 13, 2015
   Google Scholar
• NanoString Technologies®, IncPackage Insert Prosigna^® Breast Cancer Prognostic Gene Signature Assay Available from: http://prosigna.com/docs/Prosigna_Packet_Insert_US.pdfAccessed October 5, 2015
   Google Scholar
• Agendia®Mammaprint^® 70-Gene Breast Cancer Recurrence Assay Available from: http://www.agendia.com/healthcare-professionals/breast-cancer/mammaprint/Accessed November 12, 2015
   Google Scholar
• JerevallPLMaXJLiHPrognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trialBr J Cancer2011104111762176921559019
   PubMed Web of Science ®Google Scholar
• PaikSShakSTangGA multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerN Engl J Med2004351272817282615591335
   PubMed Web of Science ®Google Scholar
• PaikSTangGShakSGene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancerJ Clin Oncol200624233726373416720680
   PubMed Web of Science ®Google Scholar
• ParkerJSMullinsMCheangMCUSupervised risk predictor of breast cancer based on intrinsic subtypesJ Clin Oncol20092781160116719204204
   PubMed Web of Science ®Google Scholar
• BuyseMLoiSvan’t VeerLValidation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancerJ Natl Cancer Inst200698171183119216954471
   PubMed Web of Science ®Google Scholar
• van’t VeerLJDaiHvan de VijverMJGene expression profiling predicts clinical outcome of breast cancerNature2002415687153053611823860
   PubMed Web of Science ®Google Scholar
• HornDZhouWTrevissonEThe conserved mitochondrial twin Cx9C protein Cmc2 Is a Cmc1 homologue essential for cytochrome coxidase biogenesisJ Biol Chem201028520150881509920220131
   PubMed Web of Science ®Google Scholar
• VulstekeVBeullensMBoudrezAInhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1J Biol Chem2004279108642864714699119
   PubMed Web of Science ®Google Scholar
• LinMLParkJHNishidateTNakamuraYKatagiriTInvolvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 familyBreast Cancer Res200791R1717280616
   PubMed Web of Science ®Google Scholar
• BeullensMVancauwenberghSMorriceNSubstrate specificity and activity regulation of protein kinase MELKJ Biol Chem200528048400034001116216881
   PubMed Web of Science ®Google Scholar
• LinYCChenCCChengCJYangRBDomain and functional analysis of a novel breast tumor suppressor protein, SCUBE2J Biol Chem201128630270392704721652720
   PubMed Web of Science ®Google Scholar
• NCBI Resource CoordinatorsDatabase resources of the National Center for Biotechnology InformationNucleic Acids Res201543Database issueD61725398906
   PubMed Web of Science ®Google Scholar
• TianSRoepmanPvan’t VeerLJBernardsRde SnooFGlasAMBiological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancerBiomark Insights2010512913821151591
   PubMedGoogle Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• GoldsteinDBennettBKWebberKCancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort studyJ Clin Oncol201230151805181222508807
   PubMed Web of Science ®Google Scholar
• WielgusKKBergerAMHertzogMPredictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancerOncol Nurs Forum2009361384819136337
   PubMed Web of Science ®Google Scholar